Cargando…

Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems

Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Bryan S., Hildebrandt, Tom, Wallisch, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160254/
https://www.ncbi.nlm.nih.gov/pubmed/35650220
http://dx.doi.org/10.1038/s41598-022-13048-w
_version_ 1784719231794806784
author Nelson, Bryan S.
Hildebrandt, Tom
Wallisch, Pascal
author_facet Nelson, Bryan S.
Hildebrandt, Tom
Wallisch, Pascal
author_sort Nelson, Bryan S.
collection PubMed
description Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18–47 years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use.
format Online
Article
Text
id pubmed-9160254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91602542022-06-03 Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems Nelson, Bryan S. Hildebrandt, Tom Wallisch, Pascal Sci Rep Article Previous research has uncovered medical and psychological effects of anabolic–androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18–47 years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use. Nature Publishing Group UK 2022-06-01 /pmc/articles/PMC9160254/ /pubmed/35650220 http://dx.doi.org/10.1038/s41598-022-13048-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Nelson, Bryan S.
Hildebrandt, Tom
Wallisch, Pascal
Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title_full Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title_fullStr Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title_full_unstemmed Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title_short Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
title_sort anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160254/
https://www.ncbi.nlm.nih.gov/pubmed/35650220
http://dx.doi.org/10.1038/s41598-022-13048-w
work_keys_str_mv AT nelsonbryans anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems
AT hildebrandttom anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems
AT wallischpascal anabolicandrogenicsteroiduseisassociatedwithpsychopathyrisktakingangerandphysicalproblems